Caesarstone assigned 69.1% fault in jury verdict

Caesarstone said it is considering available actions and identified post-trial remedies and an appeal among its forward-looking matters.

Rhea-AI Filing Summary

Caesarstone Ltd. (CSTE) reported that a jury found it liable on October 26, 2026, in a case brought by plaintiff Dennys Rene Rivas-Williams in the Superior Court of California, County of Los Angeles. The jury awarded the plaintiff approximately $67.3 million and apportioned Caesarstone 69.1% of the fault, or approximately $46.5 million if assessed without modification. Caesarstone said it is considering its available actions.

0 points · 0 major

NegativeiHow this balance works

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

How the balance worksHow Sentiment works

1 major · 1 point

How the balance works

Positive

• None.

Negative

• Major point69.1% fault apportionment corresponds to approximately $46.5 million if assessed without modification. 57% of market cap

Key Figures

Jury award: Approximately $67.3 million Fault apportioned: 69.1% Apportioned damages: Approximately $46.5 million

3 metrics

Jury award Approximately $67.3 million Award to the plaintiff in the Rivas-Williams case on October 26, 2026

Fault apportioned 69.1% Caesarstone's share in the verdict on October 26, 2026

Apportioned damages Approximately $46.5 million If assessed without modification

Key Terms

silicosis, apportioned, post-trial remedies

3 terms

silicosis medical

"including silicosis"

apportioned regulatory

"apportioned 69.1% of the fault"

post-trial remedies regulatory

"expectations regarding post-trial remedies"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much did the jury award in CSTE’s Rivas-Williams case?

The jury awarded the plaintiff approximately $67.3 million and apportioned Caesarstone 69.1% of the fault, or approximately $46.5 million if assessed without modification.

What actions is CSTE considering after the verdict?

Caesarstone said it is considering its available actions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/27/2026 - 09:00 AM EDT Accepted by SEC EDGAR 10/27/2026 - 08:59 AM EDT Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C.  20549 

______________________

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

Pursuant to Rule 13a-16 or 15d-16 of the 

Securities Exchange Act of 1934

For the month of October 2026

Commission File Number: 001-35464

Caesarstone Ltd. 

(Translation of registrant’s name into English)

Kibbutz Sdot Yam 

MP Menashe 

Israel 3780400 

 (Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒      Form 40-F ☐

EXPLANATORY NOTE

As previously disclosed, Caesarstone Ltd. (the “Company”) and its subsidiaries, including Caesarstone USA, Inc., are defendants in multiple lawsuits alleging that fabricators contracted illnesses, including silicosis, through exposure to silica particles while fabricating the Company’s products.

On October 26, 2026, the jury rendered a verdict in one such case brought in the Superior Court of California, County of Los Angeles, Dennys Rene Rivas-Williams v. A&A Granite Marble, et al. (Case No. 23STCV08523), which is part of the coordinated silicosis proceeding (JCCP 5378). The jury found the Company liable and awarded the plaintiff approximately $67.3 million in damages. The Company was apportioned 69.1% of the fault, or approximately $46.5 million, if assessed without modification.

The Company is considering its available actions.

This Form 6-K is incorporated by reference into the Company’s Registration Statements on Form S-8 (Files Nos. 333-180313, 333-210444, 333-251642 and 333-295843).

Cautionary Statement Regarding Forward-Looking Statements

This Report on Form 6-K contains “forward-looking statements” within the meaning of federal securities laws. Words such as “believe,” “expect” and “intend” and similar expressions identify forward-looking statements, which include but are not limited to statements related to the Company’s expectations regarding post-trial remedies, an appeal and the ultimate outcome of the referenced lawsuit and other pending claims, the impact of the verdict on the Company’s financial condition and prospects, and the Company’s ability to obtain additional financing. This information is qualified in its entirety by the risks and uncertainties discussed under the sections “Risk Factors” and “Special Note Regarding Forward-Looking Statements and Risk Factor Summary” in the Company’s most recent annual report on Form 20-F filed with the Securities and Exchange Commission (the “SEC”) on March 4, 2026, and in other documents filed by the Company with the SEC, which are available free of charge at www.sec.gov. These forward-looking statements are made only as of the date hereof, and the Company undertakes no obligation to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	CAESARSTONE LTD.
Date: October 27, 2026	By: /s/ Nahum Trost Name: Nahum Trost Title: Chief Financial Officer